Node Pharma AS is a Norwegian AS based in Oslo, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2021, the company reported revenue of NOK 11.2m in its latest annual filing.
Å utvikle, produsere og selge produkter innenfor bioteknologisk basert diagnostikk og behandling, og tilgrensende områder. Formålet kan fremmes ved deltagelse i eller samarbeid med andre foretak i inn- og utland eller rådgivende virksomhet.
In its most recent annual report (2024), Node Pharma AS reported revenue of NOK 11.2m, an increase of 183% on the year before. The figures on this page draw on 4 annual filings covering 2021 to 2024. The bottom line showed a net loss of NOK 344.2k, and the EBITDA margin stood at -3.2%.
At the end of 2024, equity financed 34% of the balance sheet, and current assets covered short-term debt 1.5 times.
Frequently asked questions
What is the Org number of Node Pharma AS?
Node Pharma AS is registered with Brønnøysundsregistrene under Org 927025965.
What is the revenue of Node Pharma AS?
Node Pharma AS reported revenue of NOK 11.2m in 2024.
Who is the CEO of Node Pharma AS?
Tor Espen Stav-Noraas is the CEO of Node Pharma AS, in role since 2022.
Who is the chairman of Node Pharma AS?
Thomas Ramdahl chairs the board of Node Pharma AS, in role since 2025.
Where is Node Pharma AS headquartered?
Node Pharma AS's registered address is Gaustadalléen 21.
